South African variant can 'break through' Pfizer vaccine, Israeli study says
The findings come from a real-world data study in Israel that has not been peer reviewed. The researchers cautioned that the study had a small sample size of people infected with the COVID-19 variant and was not intended to deduce overall vaccine effectiveness against any variant.